دورية أكاديمية
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit.
| العنوان: | Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit. |
|---|---|
| المؤلفون: | Semb AG; Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway a-semb@diakonsyk.no., Rollefstad S; Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Ikdahl E; Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Wibetoe G; Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Sexton J; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Crowson C; Health Sciences Research, Mayo Clinic Rochester, Rochester, Minnesota, USA., van Riel P; Rheumatology, Radboud University Nijmegen, Nijmegen, The Netherlands., Kitas G; Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Dudley, UK., Graham I; Cardiology, Trinity College Dublin, Dublin, Ireland., Rantapää-Dahlqvist S; Department of Public Health and Clinical Medicine/Rheumatology, Umeå Universitet Medicinska Fakulteten, Umea, Sweden., Karpouzas GA; Internal Medicine-Rheumatology, Harbor-UCLA Medical Center, Torrance, California, USA., Myasoedova E; Division of Rheumatology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, Minnesota, USA., Gonzalez-Gay MA; Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain., Sfikakis PP; First Department of Propedeutic Medicine, Medical School of University of Athens, Athens, Greece., Tektonidou MG; First Department of Propaedeutic Internal Medicine, University of Athens, Athens, Greece., Lazarini A; 2nd Department of Medicine and Laboratory, Clinical Immunology-Rheumatology Unit, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Vassilopoulos D; 2nd Department of Medicine and Laboratory, Clinical Immunology-Rheumatology Unit, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Kuriya B; Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada., Hitchon C; Rheumatology, University of Manitoba, Winnipeg, Manitoba, Canada., Stoenoiu MS; Rheumatology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium., Durez P; Rheumatology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium., Pascual-Ramos V; Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico., Galarza-Delgado DA; Rheumatology, Charles University First Faculty of Medicine, Praha, Czech Republic., Faggiano P; Third Department of Internal Medicine, Department of Endocrinology and Metabolism, Charles University First Faculty of Medicine, Praha, Czech Republic., Misra DP; Krajska zdravotni a.s, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic., Borg AA; First Medical Faculty, Charles University, Praha, Czech Republic., Mu R; Department of Internal Medicine III-Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Olomouc, Olomoucký, Czech Republic., Mirrakhimov EM; Division of Rheumatology, 2nd Department of Internal Medicine-Gastroenterology, Charles University First Faculty of Medicine, Praha, Czech Republic., Gheta D; Medicine, Tallaght University Hospital, Dublin, Ireland., Douglas K; Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Dudley, UK., Agarwal V; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India., Myasoedova S; Rheumatology, Ivanovo State Medical Academy, Ivanovo, Ivanovskaa oblast', Russian Federation., Krougly L; Rheumatology, FSBI National Medical and Surgical Center named after N I Pirogov of the Ministry of Healthcare of the Russian Federation, Moskva, Moskva, Russian Federation., Valentinovna Popkova T; Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moskva, Moskva, Russian Federation., Tuchyňová A; Rheumatology, Narodny Ustav Reumatickych Chorob, Piestany, Slovakia., Tomcik M; Rheumatology, Charles University First Faculty of Medicine, Praha, Czech Republic., Vrablik M; Third Department of Internal Medicine, Department of Endocrinology and Metabolism, Charles University First Faculty of Medicine, Praha, Czech Republic., Lastuvka J; Krajska zdravotni a.s, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic.; First Medical Faculty, Charles University, Praha, Czech Republic., Horak P; Department of Internal Medicine III-Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Olomouc, Olomoucký, Czech Republic., Medkova HK; Division of Rheumatology, 2nd Department of Internal Medicine-Gastroenterology, Charles University First Faculty of Medicine, Praha, Czech Republic., Kerola AM; Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway. |
| مؤلفون مشاركون: | SURF-RA collaborators |
| المصدر: | RMD open [RMD Open] 2021 Jul; Vol. 7 (2). |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London : BMJ Publishing Group, [2015]- |
| مواضيع طبية MeSH: | Arthritis, Rheumatoid*/complications , Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/epidemiology , Cardiovascular Diseases*/epidemiology , Cardiovascular Diseases*/etiology , Cardiovascular Diseases*/prevention & control , Diabetes Mellitus*/drug therapy , Diabetes Mellitus*/epidemiology, Heart Disease Risk Factors ; Humans ; Risk Factors |
| مستخلص: | Aim: The objective was to examine the prevalence of atherosclerotic cardiovascular disease (ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and patients with RA without diabetes mellitus (RAwoDM), and to evaluate lipid and blood pressure (BP) goal attainment in RA-DM and RAwoDM in primary and secondary prevention. Methods: The cohort was derived from the Survey of Cardiovascular Disease Risk Factors in Patients with Rheumatoid Arthritis from 53 centres/19 countries/3 continents during 2014-2019. We evaluated the prevalence of cardiovascular disease (CVD) among RA-DM and RAwoDM. The study population was divided into those with and without ASCVD, and within these groups we compared risk factors and CVD preventive treatment between RA-DM and RAwoDM. Results: The study population comprised of 10 543 patients with RA, of whom 1381 (13%) had DM. ASCVD was present in 26.7% in RA-DM compared with 11.6% RAwoDM (p<0.001). The proportion of patients with a diagnosis of hypertension, hyperlipidaemia and use of lipid-lowering or antihypertensive agents was higher among RA-DM than RAwoDM (p<0.001 for all). The majority of patients with ASCVD did not reach the lipid goal of low-density lipoprotein cholesterol <1.8 mmol/L. The lipid goal attainment was statistically and clinically significantly higher in RA-DM compared with RAwoDM both for patients with and without ASCVD. The systolic BP target of <140 mm Hg was reached by the majority of patients, and there were no statistically nor clinically significant differences in attainment of BP targets between RA-DM and RAwoDM. Conclusion: CVD preventive medication use and prevalence of ASCVD were higher in RA-DM than in RAwoDM, and lipid goals were also more frequently obtained in RA-DM. Lessons may be learnt from CVD prevention programmes in DM to clinically benefit patients with RA . Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.) |
| التعليقات: | Erratum in: RMD Open. 2021 Aug;7(3):. (PMID: 34452976) |
| References: | Rheumatol Int. 2020 Apr;40(4):523-527. (PMID: 32088752) Eur J Prev Cardiol. 2019 May;26(8):824-835. (PMID: 30739508) Ann Rheum Dis. 2014 Jan;73(1):62-8. (PMID: 24095940) Circulation. 2014 Aug 12;130(7):546-53. (PMID: 25015340) Eur J Prev Cardiol. 2016 Jul;23(11):1202-10. (PMID: 27118362) Nat Rev Rheumatol. 2020 Jul;16(7):361-379. (PMID: 32494054) Joint Bone Spine. 2017 Jul;84(4):411-416. (PMID: 27777170) Arthritis Care Res (Hoboken). 2017 Jan;69(1):51-57. (PMID: 27696731) Arthritis Care Res (Hoboken). 2017 Oct;69(10):1495-1503. (PMID: 27998044) J Rheumatol. 2006 Nov;33(11):2167-72. (PMID: 16981296) Eur J Prev Cardiol. 2020 Aug 28;:. (PMID: 33580789) Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28. (PMID: 30559228) Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96. (PMID: 27353126) Arthritis Rheum. 2012 Sep;64(9):2836-46. (PMID: 22576673) Medicine (Baltimore). 2016 Feb;95(7):e2552. (PMID: 26886599) Ann Rheum Dis. 2012 Sep;71(9):1524-9. (PMID: 22425941) Medicine (Baltimore). 2017 Aug;96(34):e7896. (PMID: 28834907) Eur Heart J. 2020 Jan 1;41(1):12-85. (PMID: 31820000) Ann Rheum Dis. 2017 Jan;76(1):17-28. (PMID: 27697765) Ann Rheum Dis. 2017 Oct;76(10):1642-1647. (PMID: 28710095) Eur Heart J. 2020 Jan 7;41(2):255-323. (PMID: 31497854) Semin Arthritis Rheum. 2015 Jun;44(6):618-26. (PMID: 26058345) Ann Rheum Dis. 2012 Sep;71(9):1496-501. (PMID: 22402144) Musculoskeletal Care. 2011 Jun;9(2):69-74. (PMID: 21618398) Rheumatology (Oxford). 2018 Feb 1;57(2):329-336. (PMID: 29121263) Eur Heart J. 2018 Sep 1;39(33):3021-3104. (PMID: 30165516) Arthritis Rheumatol. 2019 Sep;71(9):1437-1449. (PMID: 30983166) PLoS One. 2019 Jan 17;14(1):e0201196. (PMID: 30653535) Diabetes Care. 2019 Jan;42(Suppl 1):S103-S123. (PMID: 30559236) Ann Rheum Dis. 2011 Jun;70(6):929-34. (PMID: 21389043) Atheroscler Suppl. 2020 Dec;42:e15-e24. (PMID: 33589219) Semin Arthritis Rheum. 2012 Feb;41(4):535-44. (PMID: 22340996) BMC Fam Pract. 2013 Oct 10;14:150. (PMID: 24106825) |
| فهرسة مساهمة: | Keywords: arthritis; atherosclerosis; cardiovascular diseases; hypertension; lipids; rheumatoid |
| تواريخ الأحداث: | Date Created: 20210710 Date Completed: 20210831 Latest Revision: 20220510 |
| رمز التحديث: | 20240829 |
| مُعرف محوري في PubMed: | PMC8268901 |
| DOI: | 10.1136/rmdopen-2021-001724 |
| PMID: | 34244381 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2056-5933 |
|---|---|
| DOI: | 10.1136/rmdopen-2021-001724 |